Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12134396 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL12134384 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL10316174 | 0.94 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL12134395 | 0.94 | ALDH1A1 (0.39) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL12134379 | 0.92 | ALDH1A1 (0.40) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL15000568 | 0.91 | ALDH1A1 (0.51) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL12134435 | 0.89 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL13374172 | 0.89 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL14453509 | 0.84 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL19820290 | 0.83 | ALDH1A1 (0.47) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288580-B2 | Benzophenone compound | Double Bond Chemical Ind. Co., Ltd. (TW) | 2012-10-16 | — | — | US | disclosed |
| US-20110282091-A1 | BENZOPHENONE COMPOUND | Double Bond Chemical Ind. Co., Ltd. (TW) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282091-A1 | BENZOPHENONE COMPOUND | NPM1, NR0B1, NR4A1 | SMN1; SMN2 2081/4885ALDH1A1 2353/4885TDP1 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.